No significant changes in CD4+ T cell activation, defined by HLA-DR and CD38 expression, were detected (Supplemental Figure 3, J–M); however, both pregnant and nonpregnant women had significant increases in polyfunctional CD4+ T cells expressing granzymes and perforin during acute COVID-19 (Supplemental Figure 3N). This evidence concerns the gene PRF1 and COVID-19.